ZMIZ1 and colorectal carcinoma: When exploring the effects of genetically predicted smoking-related methylation on CRC risk, we discovered two CpG sites, cg17823346 [ZMIZ1] and cg02149899, whose methylation were found to modulate CRC risk through epigenetic modification.